234
Views
4
CrossRef citations to date
0
Altmetric
Review

Implications of maternal obesity on fetal growth and the role of ultrasound

, &
Pages 45-58 | Received 21 Oct 2016, Accepted 09 Dec 2016, Published online: 26 Dec 2016

References

  • Lobstein T, Baur L, Uauy R. Obesity in children and young people: a crisis in public health. Obes Rev. 2004;5(Suppl 1):4–104. Epub 2004 Apr 21.
  • Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011;377:557–567. Epub 2011 Feb 08.
  • WHO. Obesity and overweight Geneva. 2016 [cited 2016 Sep 27]. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/
  • Wang Y, Beydoun MA, Liang L, et al. Will all Americans become overweight or obese? estimating the progression and cost of the US obesity epidemic. Obesity (Silver Spring). 2008;16:2323–2330. Epub 2008 Aug 23.
  • Ezzati M, Lopez AD, Rodgers A, et al. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360:1347–1360. Epub 2002 Nov 09.
  • Chu SY, Kim SY, Bish CL. Prepregnancy obesity prevalence in the United States, 2004-2005. Matern Child Health J. 2009;13:614–620. Epub 2008 Jul 12.
  • Scheil W, Scott J, Catcheside B, et al. Pregnancy outcome in South Australia 2010. Adelaide: Government of South Australia; 2012.
  • Scheil W, Scott J, Catcheside B, et al. Pregnancy outcome in South Australia 2010. Adelaide: Government of South Australia; 2014.
  • World Health Organisation (WHO). Consideration of the evidence on childhood obesity for the commission on ending childhood obesity: report of the ad hoc working group on science and evidence for ending childhood obesity. Geneva: World Health Organisation. 2016.
  • Li Y-P, Yang X-G, Zhai F-Y, et al. Disease risks of childhood obesity in China. Biomed Environ Sci. 2005;18:401–410.
  • Yu Z, Han S, Zhu J, et al. Pre-pregnancy body mass index in relation to infant birth weight and offspring overweight/obesity: a systematic review and meta-analysis. Plos One. 2013;8:e61627. Epub 2013 Apr 25.
  • Leng J, Li W, Zhang S, et al. GDM women’s pre-pregnancy overweight/obesity and gestational weight gain on offspring overweight status. Plos One. 2015;10:e0129536. Epub 2015 Jun 23.
  • Whitaker RC. Predicting preschooler obesity at birth: the role of maternal obesity in early pregnancy. Pediatrics. 2004;114:e29–e36.
  • Monasta L, Batty GD, Cattaneo A, et al. Early-life determinants of overweight and obesity: a review of systematic reviews. Obes Rev. 2010;11:695–708.
  • Hawkins SS, Law C. Treatment and prevention of obesity–are there critical periods for intervention? Int J Epidemiol. 2006;35:1101. author reply 2.
  • Catalano PM. Obesity and pregnancy–the propagation of a viscous cycle? J Clin Endocrinol Metab. 2003;88:3505–3506.
  • Godfery K, Reynolds R, Prescott S, et al. Influence of maternal obesity on the long-term health of offspring. Lancet Diabetes Endocrinol. 2017;5(1):53–64. Epub October 12, 2016.
  • Dodd JM, Grivell RM, Nguyen A-M, et al. Maternal and perinatal health outcomes by body mass index category. Aust N Z J Obstet Gynaecol. 2011;51:136–140. Epub 2011 Apr 07.
  • Magann EF, Doherty DA, Sandlin AT, et al. The effects of an increasing gradient of maternal obesity on pregnancy outcomes. Aust N Z J Obstet Gynaecol. 2013;53:250–257. Epub 2013 Feb 26.
  • Callaway LK, Prins JB, Chang AM, et al. The prevalence and impact of overweight and obesity in an Australian obstetric population. Med J Aust. 2006;184:56–59.
  • Sibai BM, Gordon T, Thom E, et al. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The national institute of child health and human development network of maternal-fetal medicine units. Am J Obstet Gynecol. 1995;172:642–648. Epub 1995 Feb 01.
  • Cedergren M. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol. 2004;103:219–224.
  • Doherty DA, Magann EF, Francis J, et al. Pre-pregnancy body mass index and pregnancy outcomes. Int J Gynaecol Obstet. 2006;95:242–247. Epub 2006 Sep 30.
  • Abenhaim HA, Kinch RA, Morin L, et al. Effect of prepregnancy body mass index categories on obstetrical and neonatal outcomes. Arch Gynecol Obstet. 2007;275:39–43. Epub 2006 Aug 13.
  • Athukorala C, Rumbold AR, Willson KJ, et al. The risk of adverse pregnancy outcomes in women who are overweight or obese. BMC Pregnancy and Childbirth. 2010;10:56. Epub 2010 Sep 21.
  • Kristensen J, Vestergaard M, Wisborg K, et al. Pre-pregnancy weight and the risk of stillbirth and neonatal death. Bjog. 2005;112:403–408.
  • Yao R, Ananth CV, Park BY, et al. Obesity and the risk of stillbirth: a population-based cohort study. Am J Obstet Gynecol. 2014;210:457.e1–e9. Epub 2014 Mar 29.
  • Rosenberg TJ, Garbers S, Chavkin W, et al. Prepregnancy weight and adverse perinatal outcomes in an ethnically diverse population. Obstet Gynecol. 2003;102:1022–1027. Epub 2003 Dec 16.
  • Jolly MC, Sebire NJ, Harris JP, et al. Risk factors for macrosomia and its clinical consequences: a study of 350,311 pregnancies. Eur J Obstet Gynecol Reprod Biol. 2003;111:9–14.
  • Pasupathy D, McCowan LM, Poston L, et al. Perinatal outcomes in large infants using customised birthweight centiles and conventional measures of high birthweight. Paediatr Perinat Epidemiol. 2012;26:543–552.
  • Campbell S. Fetal macrosomia: a problem in need of a policy. Ultrasound Obstet Gynaecol. 2014;43:3–10.
  • Hui L. Australian charts for assessing fetal growth: a review. ASUM Ultrasound Bulletin. 2008 Feb;2008:12–18.
  • Scioscia M, Vimercati A, Ceci O, et al. Estimation of birth weight by two-dimensional ultrasonography: a critical appraisal of its accuracy. Obstet Gynecol. 2008;111:57–65.
  • Thornburg LL, Barnes C, Glantz JC, et al. Sonographic birth-weight prediction in obese patients using the gestation-adjusted prediction method. Ultrasound Obstet Gynecol. 2008;32:66–70.
  • Gardosi J, Chang A, Kalyan B, et al. Customised antenatal growth charts. Lancet. 1992;339:283–287.
  • Gardosi J, Figueras F, Clausson B, et al. The customised growth potential: an international research tool to study the epidemiology of fetal growth. Paediatr Perinat Epidemiol. 2011;25(1):2-10.
  • Sparks JW. Human intrauterine growth and nutrient accretion. Semin Perinatol. 1984;8:74–93.
  • Sewell MF, Huston-Presley L, Super DM, et al. Increased neonatal fat mass, not lean body mass, is associated with maternal obesity. Am J Obstet Gynecol. 2006;195:1100–1103.
  • Hull HR, Dinger MK, Knehans AW, et al. Impact of maternal body mass index on neonate birthweight and body composition. Am J Obstet Gynecol. 2008;198(416):e1–e6.
  • Catalano PM, Hauguel-De Mouzon S. Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic? Am J Obstet Gynecol. 2011;204:479–487.
  • Catalano PM, Thomas A, Huston-Presley L, et al. Increased fetal adiposity: a very sensitive marker of abnormal in utero development. Am J Obstet Gynecol. 2003;189:1698–1704.
  • Oken E. Maternal and child obesity: the causal link. Obstet Gynecol Clin North Am. 2009;36:361–377.
  • Dodd JM, Catcheside B, Scheil W. Can shoulder dystocia be reliably predicted? Aust N Z J Obstet Gynaecol. 2012;52:248–252. Epub 2012 Mar 19. DOI:10.1111/j.479-828X.2012.01425.x
  • Rouse DJ, Owen J, Goldenberg RL, et al. The effectiveness and costs of elective cesarean delivery for fetal macrosomia diagnosed by ultrasound. Jama. 1996;276:1480–1486.
  • Culligan PJ, Myers JA, Goldberg RP, et al. Elective cesarean section to prevent anal incontinence and brachial plexus injuries associated with macrosomia–a decision analysis. Int Urogynecol J Pelvic Floor Dysfunct. 2005;16:19–28. discussion.
  • Boulvain M, Senat M-V, Perrotin F, et al.Induction of labour versus expectant management for large-for-date fetuses: a randomised controlled trial. Lancet. 2015;385:2600–2605.
  • Boulvain M, Irion O, Dowswell T, et al. Induction of labour at or near term for suspected fetal macrosomia. Cochrane Database Syst Rev. 2016 May 22;(5):CD000938.
  • Pedersen J. The pregnant diabetic and her newborn: problems and management. Baltimore (MD): Williams and Wilkins; 1967.
  • Catalano PM, Presley L, Minium J, et al. Fetuses of obese mothers develop insulin resistance in utero. Diabetes Care. 2009;32:1076–1080.
  • Wright C, Sibley C. Placental transfer in health and disease. In: Kay H, Nelson D, Wang Y, editors. The placenta: from development to disease. West Sussex: Wiley-Blackwell; 2011.
  • Aye IL, Powell TL, Jansson T. Review: Adiponectin–the missing link between maternal adiposity, placental transport and fetal growth? Placenta. 2013;34(Suppl):S40–S45.
  • Belkacemi L, Nelson M, Desia M, et al. Maternal undernutrition and fetal programming: role of the placenta. In: Kay H, Nelson M, Wang Y, editors. The placenta: from development to disease. West Sussex: Backwell Publishing Ltd; 2011.
  • Lewis RM, Demmelmair H, Gaillard R, et al. The placental exposome: placental determinants of fetal adiposity and postnatal body composition. Ann Nutr Metab. 2013;63:208–215. Epub 2013 Oct 8. DOI:10.1159/000355222
  • Aye ILMH, Powell TL, Jansson T. Review: adiponectin – the missing link between maternal adiposity, placental transport and fetal growth? Placenta. 2013;34(Suppl):S40–S5.
  • Dodd JM, McPhee AJ, Turnbull D, et al. The effects of antenatal dietary and lifestyle advice for women who are overweight or obese on neonatal health outcomes: the LIMIT randomised trial. BMC medicine. 2014;12:163.
  • Poston L, Bell R, Croker H, et al. Effect of a behavioural intervention in obese pregnant women (the UPBEAT study): a multicentre, randomised controlled trial. Lancet Diabetes Endocrinol. 2015;3:767–777.
  • Grivell RM, Yelland LN, Deussen A, et al. Antenatal dietary and lifestyle advice for women who are overweight or obese and the effect on fetal growth and adiposity: the LIMIT randomised trial. Bjog. 2016;123:233–243. DOI:10.1111/471-0528.13777
  • Chu SY, Kim SY, Lau J, et al. Maternal obesity and risk of stillbirth: a metaanalysis. Am J Obstet Gynecol. 2007;197:223–228.
  • Huda SS, Brodie LE, Sattar N. Obesity in pregnancy: prevalence and metabolic consequences. Semin Fetal Neonatal Med. 2010;15:70–76. Epub Nov 7. DOI:10.1016/j.siny.2009.09.006
  • Dodd JM, Robinson JS. Gestational weight loss in overweight and obese women is associated with an increased risk of small for gestational age infants. Evid Based Med. 2011;16:125–126.
  • Beyerlein A, Schiessl B, Lack N. Associations of gestational weight loss with birth-related outcome: a retrospective cohort study. Br J Obstet Gynaecol. 2011;118:55–61.
  • Lemas DJ, Brinton JT, Shapiro AL, et al. Associations of maternal weight status prior and during pregnancy with neonatal cardiometabolic markers at birth: the healthy start study. Int J Obes (2005). 2015;39:1437–1442. Epub 2015 Jun 10.
  • Uebel K, Pusch K, Gedrich K, et al. Effect of maternal obesity with and without gestational diabetes on offspring subcutaneous and preperitoneal adipose tissue development from birth up to year-1. BMC Pregnancy and Childbirth. 2014;14:138. Epub 2014 Apr 12.
  • Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991–2002. Epub 2008 May 09.
  • Sermer M, Naylor CD, Farine D, et al. The Toronto tri-hospital gestational diabetes project. A preliminary review. Diabetes Care. 1998;21(Suppl 2):B33–B42.
  • Torloni MR, Betran AP, Horta BL, et al. Prepregnancy bmi and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obesity Reviews: An Official Journal Of The International Association For The Study Of Obesity. 2009;10:194–203.
  • Son GH, Kwon JY, Kim YH, et al. Maternal serum triglycerides as predictive factors for large-for-gestational age newborns in women with gestational diabetes mellitus. Acta Obstet Gynecol Scand. 2010;89:700–704. doi:10.3109/00016341003605677
  • Vrijkotte TG, Algera SJ, Brouwer IA, et al. Maternal triglyceride levels during early pregnancy are associated with birth weight and postnatal growth. The Journal Of Pediatrics. 2011;159:736–742.e1.
  • Whyte K, Kelly H, O'Dwyer V, et al. Offspring birth weight and maternal fasting lipids in women screened for gestational diabetes mellitus (gdm). Eur J Obstet Gynecol Reprod Biol. 2013;170:67–70.
  • Schaefer-Graf UM, Graf K, Kulbacka I, et al. Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus. Diabetes Care. 2008;31:1858–1863.
  • Tessier DR, Ferraro ZM, Gruslin A. Role of leptin in pregnancy: consequences of maternal obesity. Placenta. 2013;34:205–211. Epub 2013 Jan 22.
  • Tsai PJ, Davis J, Bryant-Greenwood G. Systemic and placental leptin and its receptors in pregnancies associated with obesity. reproductive Sciences. 2015;22:189–197. doi:10.1177/1933719114537718
  • Karakosta P, Chatzi L, Plana E, et al. Leptin levels in cord blood and anthropometric measures at birth: a systematic review and meta-analysis. Paediatr Perinat Epidemiol. 2011;25:150–163. Epub 2011 Feb 02.
  • Josefson JL, Zeiss DM, Rademaker AW, et al. Maternal leptin predicts adiposity of the neonate. Horm Res Paediatr. 2014;81:13–19. Epub 2013 Dec 11. DOI:10.1159/000355387
  • Ategbo JM, Grissa O, Yessoufou A, et al. Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab. 2006;91:4137–4143.
  • Lowe LP, Metzger BE, Lowe WL Jr., et al. Inflammatory mediators and glucose in pregnancy: results from a subset of the hyperglycemia and adverse pregnancy outcome (hapo) study. J Clin Endocrinol Metab. 2010;95:5427–5434.
  • Ferraro ZM, Qiu Q, Gruslin A, et al. Characterization of the insulin-like growth factor axis in term pregnancies complicated by maternal obesity. Hum Reprod. 2012;27:2467–2475.
  • Qiu Q, Basak A, Mbikay M, et al. Role of pro-igf-ii processing by proprotein convertase 4 in human placental development. Proc Natl Acad Sci U S A. 2005;102:11047–11052.
  • Juul A. Serum levels of insulin-like growth factor i and its binding proteins in health and disease. Growth Hormone & Igf Research: Official Journal Of The Growth Hormone Research Society And The International Igf Research Society. 2003;13:113-170. doi:10.1016/S1096-6374(03)00038-8
  • Coelho M, Oliveira T, Fernandes R. Biochemistry of adipose tissue: an endocrine organ. Arch Med Sci. 2013;9:191–200.
  • Lau DCW. Molecular biology of obesity. In: Rees MCP, Karoshi M, Keith L, eds. Obesity and Pregnancy. Royal Society of Medicine Press Ltd, London, 2008;54–75.
  • Muhlhausler B, Smith SR. Early-life origins of metabolic dysfunction: role of the adipocyte. Trends Endocrinol Metab. 2009;20:51–57.
  • Symonds ME, Pope M, Sharkey D, et al. Adipose tissue and fetal programming. Diabetologia. 2012;55:1597–1606.
  • Stephens M, Ludgate M, Rees DA. Brown fat and obesity: the next big thing? Clin Endocrinol. 2011;74(6):661–670.
  • Wauters M, Considine R, Lofgren A, et al. Associations of leptin with body fat distribution and metabolic parameters in non-insulin-dependent diabetic patients: no effect of apolipoprotein E polymorphism. Metabolism. 2000;49:724–730.
  • Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86:1930–1935.
  • Catalano PM. Obesity, insulin resistance, and pregnancy outcome. Reproduction. 2010;140:365–371.
  • Farah N, Hogan AE, O’Connor N, et al. Correlation between maternal inflammatory markers and fetomaternal adiposity. Cytokine. 2012;60:96–99. Epub Jun 20. DOI:10.1016/j.cyto.2012.05.024
  • Pantham P, Aye ILMH, Powell TL. Inflammation in maternal obesity and gestational diabetes mellitus. Placenta. 2015;36:709–715.
  • Haghiac M, Yang XH, Presley L, et al. Dietary Omega-3 fatty acid supplementation reduces inflammation in obese pregnant women: a randomized double-blind controlled clinical trial. Plos One. 2015;10:e0137309.
  • Ingvorsen C, Brix S, Ozanne SE, et al. The effect of maternal inflammation on foetal programming of metabolic disease. Acta Physiol (Oxf). 2015;214:440–449. Epub 2015 Jun 15. DOI:10.1111/apha.12533
  • Rampersad R, Cervar-Zivkovic M, Nelson DM. Development and anatomy of the human placenta. In: Kay H, Nelson DM, Wang Y, editors. The placenta: from development to disease. West Sussex: Blackwell Publishing Ltd; 2011.
  • Wallace JM, Horgan S, Bhattacharya S. Placental weight and efficiency in relation to maternal body mass index and risk of pregnancy complications in women delivering singleton babies. Placenta. 2012;33:611–618.
  • Jeve YB, Konje JC, Doshani A. Placental dysfunction in obese women and antenatal surveillance strategies. Best Pract Res Clin Obstet Gynaecol. 2015;29:350–364. Epub Oct 16. DOI:10.1016/j.bpobgyn.2014.09.007
  • Clinical Standards Committee. ISUOG practice guidelines: use of Doppler ultrasonography in obstetrics. Ultraosund Obstet Gynaecol. 2013;41:233–239.
  • Sarno L, Maruotti GM, Saccone G, et al. Maternal body mass index influences umbilical artery Doppler velocimetry in physiologic pregnancies. Prenat Diagn. 2015;35:125–128.
  • Coomarasamy A, Connock M, Thornton J, et al. Accuracy of ultrasound biometry in the prediction of macrosomia: a systematic quantitative review. Br J Obstet Gynaecol. 2005;112:1461–1466.
  • Kernaghan D, Ola B, Fraser R, et al. Fetal size and growth velocity in the prediction of the large for gestational age (LGA) infant in a glucose impaired population. Eur J Obstetrics Gynaecol Reprod Biol. 2007;132:189–192.
  • Wong SF, Chan FY, Cincotta RB, et al. Sonographic estimation of fetal weight in macrosomic fetuses: diabetic versus non-diabetic pregnancies. Aust N Z J Obstet Gynaecol. 2001;41:429–432.
  • Pates JA, McIntire DD, Casey BM, et al. Predicting macrosomia. J Ultrasound Med. 2008;27:39–43.
  • El Khouly NI, Elkelani OA, Saleh SA. Amniotic fluid index and estimated fetal weight for prediction of fetal macrosomia: a prospective observational study. J Matern Fetal Neonatal Med. 2016;22:1–5.
  • Wong SF, Chan FY, Oats JJ, et al. Fetal growth spurt and pregestational diabetic pregnancy. Diabetes Care. 2002;25(10):1681–1684.
  • Culliney KA, Parry GK, Brown J, et al. Regimens of fetal surveillance of suspected large-for-gestational-age fetuses for improving health outcomes. Cochrane Database Syst Rev. 2016;4:CD011739. DOI:10.1002/14651858.CD011739.pub2
  • Bernstein IM, Catalano PM. Ultrasonographic estimation of fetal body composition for children of diabetic mothers. Invest Radiol. 1991;26:722–726.
  • Walsh JM, Wallace M, Brennan L, et al. Early pregnancy maternal urinary metabolomic profile and later insulin resistance and fetal adiposity. J Matern Fetal Neonatal Med. 2015;28:1697–1700.
  • O’Connor C, O’Higgins A, Doolan A, et al. Birth weight and neonatal adiposity prediction using fractional limb volume obtained with 3D ultrasound. Fetal Diagn Ther. 2014;36:44–48. Epub 2014 Jun 6. DOI:10.1159/000360417
  • Larciprete G, Valensise H, Vasapollo B, et al. Fetal subcutaneous tissue thickness (SCTT) in healthy and gestational diabetic pregnancies. Ultrasound Obstet Gynecol. 2003;22:591–597.
  • Hure AJ, Collins CE, Giles WB, et al. Greater maternal weight gain during pregnancy predicts a large but lean fetal phenotype: a prospective cohort study. Matern Child Health J. 2012;16:1374–1384. DOI:10.007/s10995-011-0904-8
  • Gibson KS, Stetzer B, Catalano PM, et al. Comparison of 2- and 3-dimensional sonography for estimation of birth weight and neonatal adiposity in the setting of suspected fetal macrosomia. J Ultrasound Med. 2016;35:1123–1129.
  • Walsh JM, Hehir MP, Robson MS, et al. Mode of delivery and outcomes by birth weight among spontaneous and induced singleton cephalic nulliparous labors. Int J Gynaecol Obstet. 2015;129:22–25.
  • Larciprete G, Valensise H, Vasapollo B, et al. Body composition during normal pregnancy: reference ranges. Acta Diabetol. 2003;40(Suppl 1):S225–S232.
  • Dodd JM, Turnbull D, McPhee AJ, et al. Antenatal lifestyle advice for women who are overweight or obese: LIMIT randomised trial. BMJ. 2014;348:g1285.
  • Dodd JM, Cramp C, Sui Z, et al. For the LRTG. The effects of antenatal dietary and lifestyle advice for women who are overweight or obese on maternal diet and physical activity: the LIMIT randomised trial. BMC Med. 2014;12:161. Epub 2014 Oct 16.
  • Wong SF, Lee-Tannock A, Amaraddio D, et al. Fetal growth patterns in fetuses of women with pregestational diabetes mellitus. Ultrasound Obstet Gynecol. 2006;28(7):934–938.
  • Kernaghan D, Ola B, Fraser RB, et al. Fetal size and growth velocity in the prediction of the large for gestational age (LGA) infant in a glucose impaired population. Eur J Obstet Gynecol Reprod Biol. 2007;132(2):189–192.
  • Moyer-Mileur LJ, Slater H, Thomson JA, et al. Newborn adiposity measured by plethysmography is not predicted by late gestation two-dimensional ultrasound measures of fetal growth. J Nutr. 2009;139:1772–1778.
  • Khoury FR, Stetzer B, Myers SA, et al. Comparison of estimated fetal weights using volume and 2-dimensional sonography and their relationship to neonatal markers of fat. J Ultrasound Med. 2009;28:309–315.
  • Lee W, Balasubramaniam M, Deter RL, et al. Fetal growth parameters and birth weight: their relationship to neonatal body composition. Ultrasound Obstet Gynecol. 2009;33:441–446.
  • Thangaratinam S, Rogozinska E, Jolly K, et al. Effects of interventions in pregnancy on maternal weight and obstetric outcomes: meta-analysis of randomised evidence. BMJ. 2012;344:e2088. Epub 2012 May 19.
  • Karpe F, Pinnick KE. Biology of upper-body and lower-body adipose tissue–link to whole-body phenotypes. Nature Rev Endocrinol. 2015;11:90–100.
  • Tso LO, Costello MF, Albuquerque LE, et al. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2014 Nov 18;(11):CD006105.
  • Chiswick C, Reynolds RM, Denison F, et al. Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2015;3:778–786.
  • Syngelaki A, Nicolaides KH, Balani J, et al. Metformin versus Placebo in obese pregnant women without diabetes mellitus. N Engl J Med. 2016;374:434–443.
  • Dodd JM, Deussen A, Grivell RM Metformin and dietary advice to improve insulin sensitivity and promote gestational restriction of weight in pregnant women who are obese: the GroW randomised trial. ACTRN12612001277831. 2012.
  • Rowan JA, Rush EC, Obolonkin V, et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age. Diabetes Care. 2011;34:2279–2284.
  • Rowan JA, Hague WM, Gao W, et al. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008;358:2003–2015.
  • Opray N, Grivell RM, Deussen AR, et al. Directed preconception health programs and interventions for improving pregnancy outcomes for women who are overweight or obese. Cochrane Database Syst Rev. 2015 Jul 14;(7):CD010932
  • Hanson MA, Gluckman PD, Bustreo F. Obesity and the health of future generations. Lancet Diabetes Endocrinol. 2016;4:966–967. Epub 2016 Oct 12.
  • Masie J. Pregnancy outcomes in overweight women with prior miscarriage following a structured weight loss program versus weight loss counseling (NCT01325805). 2012. Available from: http://www.clinical-trials.gov
  • Mutsaerts MA, Groen H, Ter Bogt NC, et al. The lifestyle study: costs and effects of a structured lifestyle program in overweight and obese subfertile women to reduce the need for fertility treatment and improve reproductive outcome. A randomised controlled trial. BMC Womens Health. 2010;10:22.
  • Hanson M, Barker M, Dodd JM, et al. Interventions to prevent maternal obesity before conception, during pregnancy, and post partum. The Lancet Diabetes & Endocrinology. 2017;5:65–76.
  • Moshe H, Nicolaides K, Meiri H, et al. .Introduction: Merging the legacies and hypotheses - Maternal medicine meets fetal medicine. In: Moshe H, Jovanovic L, Di Renzo C, Leiva A, Langer O, editors. Textbook of diabetes and pregnancy. Boca Raton: Taylor & Francis Group; 2016.
  • Frick AP, Syngelaki A, Zheng M, et al. Prediction of large-for-gestational-age neonates: screening by maternal factors and biomarkers in the three trimesters of pregnancy. Ultrasound Obstet Gynaecol. 2016;47:332–339.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.